OXFORD BIOMEDICA LS-,50/ GB00BDFBVT43 /
| 2024-06-03 8:14:16 AM | Chg. -0.040 | Volume | Bid5:35:13 PM | Ask5:35:13 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 3.660EUR | -1.08% | - Turnover: - |
3.800Bid Size: 800 | 4.040Ask Size: 800 | 316.98 mill.EUR | - | - |
Assets
| 2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 24.4000 | 27.5000 | 25.4000 | 31.8000 | 61.9000 | ||||||
| Intangible Assets | 1.7000 | 1.3000 | .1000 | .1000 | .1000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 2.7000 | 2.2000 | 3.3000 | 4.3000 | 2.6000 | ||||||
| Accounts Receivable | 7.4000 | 2 | 5.7000 | 15.4000 | 12.8000 | ||||||
| Cash and Cash Equivalents | 9.4000 | 15.3000 | 14.3000 | 32.2000 | 16.2000 | ||||||
| Current Assets | 25.7000 | 27.4000 | 37 | 69.5000 | 56.9000 | ||||||
| Total Assets | 51.9000 | 56.9000 | 65.4000 | 112.4000 | 122.9000 | ||||||
Liabilities
| 2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3.6000 | 1.6000 | 8.7000 | 11.4000 | 14.3000 | ||||||
| Long-term debt | 27.3000 | 34.4000 | 36.9000 | 41.2000 | - | ||||||
| Liabilities to Banks | 27.3000 | 34.4000 | 36.9000 | 41.2000 | 0.0000 | ||||||
| Provisions | 1.3000 | .6000 | .6000 | 1.6000 | 5.5000 | ||||||
| Liabilities | 41 | 44.3000 | 59.3000 | 77.7000 | 47.3000 | ||||||
| Share Capital | 25.7410 | 30.8790 | 31.0760 | 33.0340 | 38.4160 | ||||||
| Total Equity | 10.9000 | 12.6000 | 6.1000 | 34.7000 | 75.6000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 51.9000 | 56.9000 | 65.4000 | 112.4000 | 122.9000 | ||||||
Income Statement
| 2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 15.9000 | 27.8000 | 37.6000 | 66.8000 | 64.1000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -14.1000 | -11.3000 | -5.7000 | 13.9000 | -14.5000 | ||||||
| Interest Income | -2.8700 | -8.9700 | -6.0600 | -8.9300 | -6.4000 | ||||||
| Income Before Taxes | -17 | -20.3000 | -11.8000 | 5 | -20.9000 | ||||||
| Income Taxes | -4 | -3.7000 | -2.7000 | -2.5000 | -4.8000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -13 | -16.6000 | -9 | 7.5000 | -16.1000 | ||||||
Per Share
Cash Flow
| 2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -13.1000 | -5.1000 | 3 | 12.9000 | -3.5000 | ||||||
| Cash Flow from Investing Activities | -16.7000 | -6.4000 | -1.9000 | -10.1000 | -19.4000 | ||||||
| Cash Flow from Financing | 25 | 17.5000 | -2.1000 | 15.1000 | 6.9000 | ||||||
| Decrease / Increase in Cash | -4.8000 | 6 | -1 | 17.9000 | -16 | ||||||
| Employees | 231 | 256 | 321 | 432 | 554 | ||||||
